es, providing products and services for individuals and healthcare services throughout 105 countries. TENA(R) provides a full range of absorbent products tailored to the distinct needs of men and women, including pantiliners, daytime and overnight pads, male guards, protective underwear, briefs, skin care products, and underpads. TENA(R) is at the forefront of products that minimize the impact of incontinence and improve the everyday lives of people living or working with bladder weakness or incontinence. TENA(R) products feature innovative technologies, such as comfortable QuickDry(TM) topsheets, super-absorbent Lock Away Core(TM), and Advanced Odor Protection, to ensure protection, comfort and discretion for wearers. For more information, please visit: www.tena.us
TENA(R) is owned by SCA, a global consumer goods and paper company based in Sweden, which develops, produces and markets personal care products, tissue, packaging solutions, publication papers and solid-wood products.
TENA(R) and Serenity(R) are registered trademarks of SCA Hygiene Products.
About Breast Cancer Network of Strength
Breast Cancer Network of Strength(R) provides immediate emotional relief to anyone affected by breast cancer through the YourShoes(TM) 24/7 breast cancer support center, which includes the country's only toll-free hotline staffed exclusively by breast cancer survivors.
For more information about Breast Cancer Network of Strength, visit www.networkofstrength.org. Peer counselors can be contacted at 1-800-221-2141, with interpreters available in more than 150 languages.
(1) SCA will make a monetary donation for each package purchased, up to $270,000.
(2) Jemal A, Siegel R, Ward E, MurrPage: 1 2 3 4 Related medicine news :1
. Genes Linked to Spread of Breast Cancer2
. New universal breast cancer marker predicts recurrence and clinical outcome3
. Novel gene predicts local recurrence in early onset breast cancer4
. Transatlantic alliance supports breast cancer research5
. Go Pink on Mothers Day to Fight Breast Cancer6
. Novel gene predicts local recurrence in early-onset breast cancer7
. Research opens up new horizons to the design of customized medicines against breast cancer8
. Clarient Launches New Breast Cancer Test9
. Junghans named PI in $5.9 million breast cancer grant10
. African-American women still have poorer breast cancer outcomes11
. Georgetowns Lombardi Comprehensive Cancer Center and the Capital Breast Care Center Pound the Pavement to Save Lives